| RS2489292482 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS2489293675 |
APTX
|
Health Risk |
Likely pathogenic |
— |
| RS2489308738 |
SPAG1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2489323420 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS2489325501 |
IFT74
|
Health Risk |
Likely pathogenic |
— |
| RS2489327427 |
CDKN2A
|
Health Risk |
Pathogenic |
Melanoma-pancreatic cancer syndrome, Melanoma-pancreatic cancer syndrome |
| RS2489328224 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Melanoma-pancreatic cancer syndrome |
| RS2489331579 |
RIGI
|
Health Risk |
Likely pathogenic |
RIGI-related disorder, RIGI-related disorder |
| RS2489335458 |
IFT74
|
Health Risk |
Pathogenic |
— |
| RS2489349339 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS2489397090 |
CDKN2B
|
Health Risk |
Likely pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2489422392 |
IFT74
|
Health Risk |
Likely pathogenic |
— |
| RS2489423803 |
IFT74
|
Health Risk |
Pathogenic |
— |
| RS2489446259 |
TOPORS
|
Health Risk |
Likely pathogenic |
— |
| RS2489446452 |
TOPORS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 31, Retinitis pigmentosa 31 |
| RS2489447196 |
SPAG1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS2489448115 |
APTX
|
Health Risk |
Likely pathogenic |
Ataxia, early-onset |
| RS2489451154 |
CEP78
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy and hearing loss 1, Cone-rod dystrophy and hearing loss 1 |
| RS2489453836 |
APTX
|
Health Risk |
Pathogenic |
Ataxia, early-onset |
| RS2489471559 |
CEP78
|
Health Risk |
Pathogenic |
— |
| RS2489471624 |
CEP78
|
Health Risk |
Pathogenic |
— |
| RS2489493326 |
IFT74
|
Health Risk |
Likely pathogenic |
— |
| RS2489513250 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS2489527464 |
CEP78
|
Health Risk |
Pathogenic |
— |
| RS2489528087 |
SMC5
|
Health Risk |
Pathogenic |
Atelis syndrome 2, Atelis syndrome 2 |
| RS2489534334 |
CEP78
|
Health Risk |
Pathogenic |
— |
| RS2489556719 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2489566711 |
RORB
|
Health Risk |
Likely pathogenic |
— |
| RS2489566873 |
RORB
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2489566956 |
RORB
|
Health Risk |
Likely pathogenic |
Epilepsy, idiopathic generalized |
| RS2489580480 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2489580541 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489580920 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489583038 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Sialuria, GNE myopathy |
| RS2489583237 |
RORB
|
Health Risk |
Likely pathogenic |
— |
| RS2489583296 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2489583468 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2489583729 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2489583944 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2489584021 |
APTX
|
Health Risk |
Pathogenic |
— |
| RS2489584080 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS2489584226 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2489584321 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2489584567 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2489584908 |
RORB
|
Health Risk |
Likely pathogenic |
— |
| RS2489584914 |
RORB
|
Health Risk |
Likely pathogenic |
— |
| RS2489587191 |
TMC1
|
Health Risk |
Pathogenic |
— |
| RS2489590578 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2489590641 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2489591319 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489591806 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489592662 |
GNE
|
Health Risk |
Likely pathogenic |
Sialuria, GNE myopathy |
| RS2489624195 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
GNE myopathy, Sialuria |
| RS2489625957 |
RORB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2489626107 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2489626297 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2489629497 |
PSAT1
|
Health Risk |
Pathogenic |
Neu-Laxova syndrome 2, Neu-Laxova syndrome 2 |
| RS2489629517 |
PSAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neu-Laxova syndrome 2, PSAT deficiency |
| RS2489631969 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489633707 |
SPAG1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS2489633918 |
RORB
|
Health Risk |
Likely pathogenic |
— |
| RS2489639626 |
RORB
|
Health Risk |
Pathogenic |
Epilepsy, idiopathic generalized |
| RS2489639860 |
PSAT1
|
Health Risk |
Pathogenic |
Neu-Laxova syndrome 2, Neu-Laxova syndrome 2 |
| RS2489640547 |
PSAT1
|
Health Risk |
Pathogenic |
Neu-Laxova syndrome 2, Neu-Laxova syndrome 2 |
| RS2489644879 |
PSAT1
|
Health Risk |
Pathogenic |
PSAT1-related disorder, Neu-Laxova syndrome 2 |
| RS2489645698 |
PSAT1
|
Health Risk |
Likely pathogenic |
PSAT1-related disorder, Neu-Laxova syndrome 2 |
| RS2489648663 |
RORB
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizure, RORB-related disorder |
| RS2489648829 |
RORB
|
Health Risk |
Pathogenic |
— |
| RS2489648843 |
RORB
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizure, Seizure |
| RS2489650770 |
PSAT1
|
Health Risk |
Likely pathogenic |
Neu-Laxova syndrome 2, Neu-Laxova syndrome 2 |
| RS2489662458 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489663928 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2489664378 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489677535 |
RFX3
|
Health Risk |
Likely pathogenic |
— |
| RS2489679993 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS2489680991 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489681092 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489681238 |
IFT74
|
Health Risk |
Likely pathogenic |
— |
| RS2489684511 |
RFX3
|
Health Risk |
Likely pathogenic |
RFX3-related disorder, RFX3-related disorder |
| RS2489688253 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS2489696870 |
PSAT1
|
Health Risk |
Pathogenic |
Neu-Laxova syndrome 2, Neu-Laxova syndrome 2 |
| RS2489697040 |
PSAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
PSAT1-related disorder, Neu-Laxova syndrome 2 |
| RS2489715788 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489715838 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489716585 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489716716 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2489717259 |
GNE
|
Health Risk |
Pathogenic |
— |
| RS2489717397 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489717760 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2489718499 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS2489719092 |
TMC1
|
Health Risk |
Pathogenic |
— |
| RS2489719475 |
TMC1
|
Health Risk |
Pathogenic |
— |
| RS2489720722 |
IFT74
|
Health Risk |
Pathogenic |
— |
| RS2489733992 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS2489734182 |
TG
|
Health Risk |
Likely pathogenic |
— |
| RS2489734471 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS2489735126 |
GNE
|
Health Risk |
Likely pathogenic |
Sialuria, GNE myopathy |
| RS2489737917 |
TG
|
Health Risk |
Pathogenic |
— |
| RS2489784650 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS2489785254 |
GNE
|
Health Risk |
Likely pathogenic |
— |